Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lamprecht

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Clinical and Experimental Rheumatology|June 10, 2025
Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosisLuise Schumacher, Antje Müller, Andreas Koch, et al.
Clinical and Experimental Rheumatology|April 8, 2011
Antimicrobial peptides in nasal secretion and mucosa with respect to S. aureus colonisation in Wegener´s granulomatosisYuan Hui, Janet Wohlers, Rainer Podschun, et al.
Deutsche Medizinische Wochenschrift (1946)|January 9, 2020
[Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis]Kirsten de Groot, Peer Malte Aries, Marion Haubitz, et al.
Deutsche Medizinische Wochenschrift (1946)|April 27, 2019
[Actual Treatment Options for Giant Cell Arteritis]Frank Moosig, Marc Schmalzing, Peer Malte Aries, et al.
Clinical and Experimental Rheumatology|May 30, 2012
Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centresJan Loock, Jörg Henes, Ina Kötter, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 7, 2026
Role of neutrophils in regulating vascular permeability in inflammatory and autoimmune diseasesReza Akbarzadeh, Manu Beerens, Jens Y Humrich, et al.
Arthritis and Rheumatism|March 4, 2008
Clinical images: Saddlenose deformity caused by destructive granulomatous inflammation in Wegener's granulomatosisKonstanze Holl-Ulrich, Marcus Both, Stefan Gottschlich, et al.
Clinical and Experimental Rheumatology|April 24, 2010
gammadelta T-cells: basic features and potential role in vasculitisDieter Kabelitz, Juliane Fazio, Sabine Adam-Klages, et al.
Frontiers in Immunology|April 19, 2021
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic DiseasesHanna Graßhoff, Sara Comdühr, Luisa R Monne, et al.
Rheumatology (Oxford, England)|May 20, 2022
Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritisSara Comdühr, Alexander Dübbers, Lars Tharun, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Rheumatology|June 10, 2025
Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosisLuise Schumacher, Antje Müller, Andreas Koch, et al.
Clinical and Experimental Rheumatology|April 8, 2011
Antimicrobial peptides in nasal secretion and mucosa with respect to S. aureus colonisation in Wegener´s granulomatosisYuan Hui, Janet Wohlers, Rainer Podschun, et al.
Deutsche Medizinische Wochenschrift (1946)|January 9, 2020
[Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis]Kirsten de Groot, Peer Malte Aries, Marion Haubitz, et al.
Deutsche Medizinische Wochenschrift (1946)|April 27, 2019
[Actual Treatment Options for Giant Cell Arteritis]Frank Moosig, Marc Schmalzing, Peer Malte Aries, et al.
Clinical and Experimental Rheumatology|May 30, 2012
Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centresJan Loock, Jörg Henes, Ina Kötter, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 7, 2026
Role of neutrophils in regulating vascular permeability in inflammatory and autoimmune diseasesReza Akbarzadeh, Manu Beerens, Jens Y Humrich, et al.
Arthritis and Rheumatism|March 4, 2008
Clinical images: Saddlenose deformity caused by destructive granulomatous inflammation in Wegener's granulomatosisKonstanze Holl-Ulrich, Marcus Both, Stefan Gottschlich, et al.
Clinical and Experimental Rheumatology|April 24, 2010
gammadelta T-cells: basic features and potential role in vasculitisDieter Kabelitz, Juliane Fazio, Sabine Adam-Klages, et al.
Frontiers in Immunology|April 19, 2021
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic DiseasesHanna Graßhoff, Sara Comdühr, Luisa R Monne, et al.
Rheumatology (Oxford, England)|May 20, 2022
Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritisSara Comdühr, Alexander Dübbers, Lars Tharun, et al.
Pageof 14